Printer Friendly

COMPANY INFORMATION
BioSyent Inc. 5-2601 Matheson Blvd E Mississauga, ON L4W 5A8 Tel: (905) 206-0013 Fax: (905) 206-1413 Contact Name René C. Goehrum Industry Pharmaceuticals		Key Executives René C. Goehrum, CEO Alfred D'Souza, CFO Develops, acquires and commercializes proprietary science-based technologies for products which advance human health, public safety as well as the value of agricultural production.
FP ADVISOR COVERAGE BioSyent Inc. • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF JAN 28/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/RX $0.06 $0.15 $0.03 n.a. n.a. n.a. 1.54 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 8,225 n.a. $-0.02 Sept. 30/09 160.0% -23.47% -13.6% $687
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 1,102 1,104 1,514 Net income (288) (126) 383 Total assets 1,136 1,309 1,455 $ $ $ Earnings per share* (0.02) (0.01) 0.03 % % % Return on equity (29.16) (10.74) 37.62   * Common

COMPANY NEWS

Results for 'BioSyent Inc.' from past 30 days: No hits. (Links are to articles.)